Although systematic investigations are lacking to date, in a patient with a lung squamous cell carcinoma bearing a missense mutation in the ERBB4 gene (p.Arg847His), afatinib showed some efficacy, but the tumor also carried an EGFR amplification176. This evidence concerns the gene ERBB4 and squamous cell lung carcinoma.